» Articles » PMID: 22250183

Screening Older Cancer Patients: First Evaluation of the G-8 Geriatric Screening Tool

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2012 Jan 18
PMID 22250183
Citations 304
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests.

Patients And Methods: Analyses were based on 364 cancer patients aged>70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini-Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed.

Results: The prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%).

Conclusion: The G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA.

Citing Articles

A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.

Hino K, Nishina T, Koizumi M, Marui K, Kokubu M, Numata Y Int J Clin Oncol. 2025; .

PMID: 40011378 DOI: 10.1007/s10147-025-02717-1.


The Impact of Immune-Related Adverse Event Severity on Prognosis in Elderly Patients With Nonsmall-Cell Lung Cancer in First-Line Immune Checkpoint Inhibitor Treatment.

Miyamoto I, Shimizu T, Hanamura M, Mizuno Y, Nakayama R, Kusahana R Thorac Cancer. 2025; 16(3):e70006.

PMID: 39901355 PMC: 11790473. DOI: 10.1111/1759-7714.70006.


The development and validation testing of a comprehensive frailty assessment in women with breast cancer.

Huang S, Tseng L, Huang C, Lien P, Fang S, Hong Y BMC Womens Health. 2025; 25(1):46.

PMID: 39901143 PMC: 11789291. DOI: 10.1186/s12905-025-03577-7.


Immune-related adverse events in older adults receiving immune checkpoint inhibitors: a comprehensive analysis of the Food and Drug Administration Adverse Event Reporting System.

Esen B, Bektas S, Topcu U, Koylu B, Kuvvet F, Bahat G Age Ageing. 2025; 54(1).

PMID: 39883592 PMC: 11781319. DOI: 10.1093/ageing/afaf008.


Assessment of Geriatric Problems and Risk Factors for Delirium in Surgical Medicine: Protocol for Multidisciplinary Prospective Clinical Study.

Mollmann H, Alhammadi E, Boulghoudan S, Kuhlmann J, Mevissen A, Olbrich P JMIR Res Protoc. 2025; 14:e59203.

PMID: 39841510 PMC: 11799817. DOI: 10.2196/59203.